2012
DOI: 10.1371/journal.pbio.1001373
|View full text |Cite
|
Sign up to set email alerts
|

Inclusion of Residual Tissue in Biobanks: Opt-In or Opt-Out?

Abstract: This paper reviews the key arguments of the two predominant methods for the inclusion of human residual tissue in biobanks: opt-in and opt-out.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
47
0
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(48 citation statements)
references
References 63 publications
(71 reference statements)
0
47
0
1
Order By: Relevance
“…[1][2][3][4][5] A biobank can be defined as a collection of human biological samples stored for medical-scientific research purposes, usually linked to phenotypic data in one way or another. [6][7][8] Hence, the primary goal of biobanks is to facilitate research, not to provide medical care. The inclusion of children in biobanks brings forward specific ethical issues.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3][4][5] A biobank can be defined as a collection of human biological samples stored for medical-scientific research purposes, usually linked to phenotypic data in one way or another. [6][7][8] Hence, the primary goal of biobanks is to facilitate research, not to provide medical care. The inclusion of children in biobanks brings forward specific ethical issues.…”
Section: Introductionmentioning
confidence: 99%
“…Giesbertz defines residual samples as leftover tissue obtained in the course of clinical care that can be included or collected through an opt-in method (a person explicitly expresses consent to include residual tissue) or an opt-out method and the tissue is stored unless a person explicitly refuses [34] . He further notes that the "opt in" is an appropriate approach to collect residual samples.…”
Section: Discussionmentioning
confidence: 99%
“…However, the expansion of Biobanks and rapid developments in biomedical research underscore the need to evaluate the proper procedure, as each community will be different. Nonetheless, the development of Biobank has caused many legal and ethical issues to arise ranging from the need for community consultation, informed consent, legal measures enacted to protect patients and researchers, and reporting of return results [34][35][36] . Additionally, researchers need to have a better understanding of the reason for low opt-out rates.…”
Section: Discussionmentioning
confidence: 99%
“…the clinical laboratory) to officially release the post-retention tissue, (2) the future stewards (e.g. the research biobank) to officially accept the tissue and (3) the REB to provide oversight for considerations around specific research consent for banking of tissue for future research and proper de-identification/coding of samples [6,16,17]. After these prerequisites are fulfilled, the post-retention DT becomes RT and there is an official transfer of stewardship from the clinical laboratory to the research biobank.…”
Section: Post-retention Dt As a Source Of Rtmentioning
confidence: 99%